Clinical Trial Update: Study of Gelesis100 on Body Weight in Overweight and Obese Subjects With and Without Type 2 Diabetes [NA]

View source ↗

Summary

Clinical trial update for Gelesis100 in overweight and obese adults, with and without Type 2 diabetes, completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Overweight
• Type 2 Diabetes Mellitus

Drugs mentioned

• Gelesis100

Snippet

Sponsor: Gelesis, Inc. | Conditions: Overweight, Obesity | NA | Status: COMPLETED | Results posted: 2022-08-30